Conduct↦Statistic Methodology↦Safety and Efficacy Evaluation↦Procedures
What is it? Why is it important?
For an evaluation of the study's safety and efficacy during study conduct, the SP-INV implements the planned Interim Analyses (IA). IAs are performed as described in the study protocol and, if applicable, the Statistical Analysis Plan (SAP).
Results of the IA are usually provided to a Data Safety Monitoring Committee (DSMC) also named an Independent Data Monitoring Committee (IDMC). The committee advises the SP-INV on how to proceed with the study.
Note: The introduction of not-planned IAs or the omission of a planned IA, requires a protocol amendment. An amendment must be approved by the Ethics Committee (EC) and, if applicable, RA (e.g. Swissmedic for risk-category B and C studies).
What do I need to do?
As a SP-INV:
- Ensure that the IA/AIs are performed as specified in the study protocol or Statistical Analysis Plan (SAP)
- Ensure that the results are provided to the designated body (e.g. IDMC) Perform the IA(s) as described in the study protocol or SAP. In the event of a blinded study
- Obtain recommendations from the designated body (e.g. the IDMC) and make an informed decision on how to proceed with the study
Decisions may include to:
- Continue the study as planned
- Continue the study with needed modifications (e.g. changes to the study's inclusion/exclusion criteria or sample size adjustments)
- Temporarily suspend participant enrolment pending further recommendations from relevant bodies (e.g. DSMC/IDMC, swissethics (EC), Swissmedic, or the marketing authorisation holder)
- Terminate the study early
Where can I get help?
Your local Research Support Centre↧ can assist you with experienced staff regarding this topic
Basel, Departement Klinische Forschung (DKF), dkf.unibas.ch
Lugano, Clinical Trials Unit (CTU-EOC), ctueoc.ch
Bern, Department of Clinical Research (DCR), dcr.unibe.ch
Geneva, Clinical Research Center (CRC), crc.hug.ch
Lausanne, Clinical Research Center (CRC), chuv.ch
St. Gallen, Clinical Trials Unit (CTU), h-och.ch
Zürich, Clinical Trials Center (CTC), usz.ch
SCTO Research Tools & Resources
References
CH GCP E6(R3) – see in particular
- Glossary: Definition interim clinical trial
- Essential records table: Interim and final clinical reports
- 3.16.1p,q Data handling and data analysis
- 3.16.2a Study report
- B10.1 Statistical considerations
- C.3s Essentiality of trials records
ICH Topic E9 – see in particular
- 4 Trial conduct considerations
- 4.1 Trial monitoring and interim analysis
- 4.2 Changes in inclusion and exclusion criteria
- Sample size adjustments
- 4.5 Interim Analysis and early stopping
- 4.6 Role of IDMC
- 7.1 Evaluation and reporting
ICH Topic E8(R1) General considerations for clinical studies - see in particular
- 6.1.4 Access to interim data
Swiss Law
ClinO – see in particular article
- Art. 2b Definition of intervention
ClinO-MD – see in particular article
- Art. 2a Definition of clinical intervention
- Art. 2a Definition of performance study
HRO – see in particular article
- Art. 3a Definition of research